Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1177/1073274817729069 http://scihub22266oqcxt.onion/10.1177/1073274817729069 C5937241!5937241!28975824     free     free     free Deprecated: Implicit conversion from float 215.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 215.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Cancer+Control 2017 ; 24 (5): ä Nephropedia Template TP {{tp|p=28975824|t=2017. A Case Report of Steroid Responsive Nivolumab-Induced Encephalitis |pdf=|usr=}}{{28975824}} gab.com Text A Case Report of Steroid Responsive Nivolumab-Induced Encephalitis JO: Cancer Control http://www.kidney.de/pget.php?&tw=1&pmid=28975824 #FOAvip Nivolumab (Opdivo) approval for the treatment of non-small cell lung cancer (NSCLC) prompts recognition of its future use in various cancers. Although rare, occurring in 1% to 3% of treated cases, nivolumab along with other immune checkpoint inhibitors are associated with immune-related encephalitis. With its prospective use, nivolumab-induced encephalitis illustrates the necessity of early recognition and successful management to decrease morbidity and mortality. We describe a treated case of nivolumab-induced encephalitis. A 74-year-old male with a history of stage 4 squamous NSCLC presenting with insidious altered mental status following his first dose of nivolumab. After an extensive workup that proved negative, the patient received intravenous steroids with gradual improvement of mental status. Patient subsequently returned to baseline and was discharged with oral steroid taper. Nivolumab-induced encephalitis is a diagnosis of exclusion with nonspecific signs and symptoms. Immediate recognition of patients prescribed nivolumab chemotherapy could potentially prevent fatal complications of neurotoxicity. Twit Text FOAVip A Case Report of Steroid Responsive Nivolumab-Induced Encephalitis ????Cancer Control http://www.kidney.de/pget.php?&tw=1&pmid=28975824 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=28975824 #FOAvip English Wikipedia <ref>{{Cite pmid|28975824}}</ref> A Case Report of Steroid Responsive Nivolumab-Induced Encephalitis #MMPMID28975824 Richard K; Weslow J; Porcella SL; Nanjappa S Cancer Control 2017[Dec]; 24 (5): ä PMID28975824show ga Nivolumab (Opdivo) approval for the treatment of non-small cell lung cancer (NSCLC) prompts recognition of its future use in various cancers. Although rare, occurring in 1% to 3% of treated cases, nivolumab along with other immune checkpoint inhibitors are associated with immune-related encephalitis. With its prospective use, nivolumab-induced encephalitis illustrates the necessity of early recognition and successful management to decrease morbidity and mortality. We describe a treated case of nivolumab-induced encephalitis. A 74-year-old male with a history of stage 4 squamous NSCLC presenting with insidious altered mental status following his first dose of nivolumab. After an extensive workup that proved negative, the patient received intravenous steroids with gradual improvement of mental status. Patient subsequently returned to baseline and was discharged with oral steroid taper. Nivolumab-induced encephalitis is a diagnosis of exclusion with nonspecific signs and symptoms. Immediate recognition of patients prescribed nivolumab chemotherapy could potentially prevent fatal complications of neurotoxicity. äA Case Report of Steroid Responsive Nivolumab-Induced Encephalitis (epmc).pdf DeepDyve Pubget Overpricing